Transformative advancements in immune checkpoint inhibitor therapy for Oropharyngeal Squamous Cell Carcinoma (OPSCC)

Advancements in Immune checkpoint inhibitor (ICI) treatment have greatly changed the way oropharyngeal squamous cell carcinoma (OPSCC) is treated. This paper examines the crucial advancements and their consequences for clinical practice. Initially, the implementation of ICIs, such as pembrolizumab a...

Descripció completa

Dades bibliogràfiques

Autors principals:	Iadalin Ryntathiang, Mukesh Kumar Dharmalingam Jothinathan
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2024-09-01
Col·lecció:	Oral Oncology Reports
Matèries:	Immune checkpoint inhibitor (ICI) Oropharyngeal squamous cell carcinoma (OPSCC) Tumor microenvironment Pembrolizumab Nivolumab
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2772906024004102
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!